ESPE Abstracts

The use of insulin pumps is increasing particularly in the paediatric population with between 50% to 74% pump users below the age of 6 years. Real-time continuous glucose monitoring enables greater understanding of glucose excursions, provides low and high glucose alarms, and facilitates more responsive insulin dose adjustments. An enhancement of the sensor-augmented insulin therapy pump is the low-glucose suspend (LGS) and predictive low glucose management (PLGM) features red...